Fig. 1.
Fig. 1. The +24 base pair mutation cosegregates with melanoma and myeloma in family A, and the wild type allele is deleted in the malignant plasma cells of patient No. II:1. / Shaded members denote cancer development with the cancer type given below. The arrow indicates the proband with multiple myeloma. Four individuals in family A have developed melanoma (patients No. I:1, II:2, II:5, and II:7). The positions of the wild type, mutant, and heteroduplex bands are indicated on the right-hand side of the figure. Note that all 5 individuals harboring the +24 mutation have developed cancer, while patients No. I:2, II:4, and II:6 are wild type for both alleles and have not developed any malignancy. (DNA was not available for patient No. II:3.) On the left side of the figure, the PCR reactions from germline, unsorted BM, and sorted BM cells are shown under patient No. II:1. Note that the LOH of the wild typeCDKN2A allele is seen only in the sorted (greater than 90% malignant plasma cells) obtained from this individual. Importantly, there is a large decrease in the amount of heteroduplex DNA present in the sorted BM sample, which was again due to lack of the wild type PCR product.

The +24 base pair mutation cosegregates with melanoma and myeloma in family A, and the wild type allele is deleted in the malignant plasma cells of patient No. II:1.

Shaded members denote cancer development with the cancer type given below. The arrow indicates the proband with multiple myeloma. Four individuals in family A have developed melanoma (patients No. I:1, II:2, II:5, and II:7). The positions of the wild type, mutant, and heteroduplex bands are indicated on the right-hand side of the figure. Note that all 5 individuals harboring the +24 mutation have developed cancer, while patients No. I:2, II:4, and II:6 are wild type for both alleles and have not developed any malignancy. (DNA was not available for patient No. II:3.) On the left side of the figure, the PCR reactions from germline, unsorted BM, and sorted BM cells are shown under patient No. II:1. Note that the LOH of the wild typeCDKN2A allele is seen only in the sorted (greater than 90% malignant plasma cells) obtained from this individual. Importantly, there is a large decrease in the amount of heteroduplex DNA present in the sorted BM sample, which was again due to lack of the wild type PCR product.

Close Modal

or Create an Account

Close Modal
Close Modal